Medicare National Coverage Determinations (NCD) Manual (Pub. 100-03), Ch. 1 § 20.12
Diagnostic Endocardial Electrical Stimulation (Pacing)
20.12 - Diagnostic Endocardial Electrical Stimulation (Pacing)
(Rev. 1, 10-03-03)
CIM 35-78
Diagnostic endocardial electrical stimulation (EES), also called programmed electrical
stimulation of the heart, is covered under Medicare when used for patients with severe
cardiac arrhythmias.
Diagnostic endocardial electrical stimulation involves the detection and stimulation of
cardiac electrical activity for the purpose of studying arrhythmias and abnormalities of
the heart’s conduction system. Intracardiac electrode catheters, intracardiac and
extracardiac recordings and a stimulator device are required. From two to six multi-polar
electrode catheters are inserted percutaneously, usually through the femoral veins, and
advanced to the heart under fluoroscopic control. Other venous or arterial routes may be
employed as well. An intracardiac His bundle cardiogram is usually obtained during EES
as are conventional electrocardiograms. No separate charge will be recognized for the
His Bundle cardiogram. (See §20.16.)
The EES is used to investigate the mechanisms, site of origin and pathways of cardiac
arrhythmias as well as to select therapeutic approaches for their resolution. EES is also
employed to identify patients at risk of sudden arrhythmic death. The principal use for
EES is in the diagnosis and treatment of sustained ventricular tachycardia. However, it
has also proven to be of value in the diagnosis and management of other complex
arrhythmias, conduction defects, and after cardiac arrest.